Orthostatic Hypotension and Diabetes Mellitus
ODET
The Orthostatic Hypotension in the Diabetic Elderly Patients Trial (ODET)
1 other identifier
observational
500
1 country
1
Brief Summary
Rationale: Orthostatic hypotension increases with age and is associated with increased vascular and all-cause mortality. The prevalence of orthostatic hypotension is also increased in diabetic subjects. In order to prevent related adverse events and vascular mortality it is of great interest to examine the prevalence of orthostatic hypotension in elderly diabetic subjects. Objective: To examine the prevalence of orthostatic hypotension and associated adverse events in type 2 diabetic elderly subjects. Study design: Cross-sectional observational study. Study population: Elderly type 2 diabetic subjects (70 years and older).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 11, 2008
CompletedFirst Posted
Study publicly available on registry
December 15, 2008
CompletedStudy Start
First participant enrolled
January 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2010
CompletedOctober 8, 2010
October 1, 2010
1.3 years
December 11, 2008
October 7, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of orthostatic hypotension
1-12 months (orthostatic blood pressure is assessed only once during the running time of the study)
Secondary Outcomes (1)
Adverse events, Score risk profile questionnaire, Heart rate, Gender, Body mass index, Medication, Smoking, History of cardiovascular disease, Family history of cardiovascular disease, Duration of diabetes mellitus, Glycosylated haemoglobin, Insulin use
1-12 months (the outcome measures are assessed only once during the running time of the study)
Study Arms (2)
Study group
Type 2 diabetic patients aged 70 years and older.
Control group
Patients aged 70 years and older, with no history of type 2 diabetes mellitus.
Eligibility Criteria
Type 2 diabetic patients aged 70 years and older
You may qualify if:
- diabetes mellitus
- age (70 years and older)
You may not qualify if:
- Known autonomic dysfunction
- Neurodegenerative diseases
- Current malignancy
- Living in a nursing-home
- Irregular pulse
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Diabetes centre, Isala Clinics
Zwolle, 8000 GM, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kornelis JJ van Hateren, MD
Diabetes centre, Isala Clinics
Study Design
- Study Type
- observational
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 11, 2008
First Posted
December 15, 2008
Study Start
January 1, 2009
Primary Completion
May 1, 2010
Study Completion
May 1, 2010
Last Updated
October 8, 2010
Record last verified: 2010-10